DiscoverThe Carlat Psychiatry PodcastCobenfy: A New Antipsychotic
Cobenfy: A New Antipsychotic

Cobenfy: A New Antipsychotic

Update: 2024-10-07
Share

Description

KarXT (Cobenfy) is the first antipsychotic that doesn’t block dopamine. We trace the origins of this new drug to a South Asian herb used for over 5,000 years, up to the three EMERGENT trials that led to its FDA approval.


CME: Take the CME Post-Test for this Episode

Published On: 10/07/2024

Duration: 12 minutes, 28 seconds


Chris Aiken and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Cobenfy: A New Antipsychotic

Cobenfy: A New Antipsychotic

Pocket Psychiatry: A Carlat Podcast